LivePerson, Inc. (NASDAQ:LPSN) Q4 2023 Earnings Call Transcript

So we are executing a classic transformation strategy that really has to do with setting where we’re going, clearly communicating it to the customer, bringing in leaders to which I’ve already spoken to help augment the current team that we have today through that transformation and making sure that we have a robust set of capabilities on reporting, process and operations to ensure that we’re moving forward on these transformations. And that’s where I’d really like to highlight why I came to this company. These things that need to be improved are the things I’ve seen in past companies. And over the course of quarters, we were able to make substantial improvements with them that had dramatic improvements to ARR consumption and value with the customer and ultimately new local growth and growth to the company overall.

John Collins: I’d like to add before we move on. We have had, as the investor base and analyst community is very aware, a lot of non-core initiatives over the past few years that have caused substantial distraction to the wider employee base and the leadership team. Over the last six months, however, we have become more focused than ever on the core value proposition this company brings to its enterprise customer base. And I think what we’re seeing now in John’s plan is that we’re putting the meat on the bones of that newfound focus that we already have. So I think the company and the leadership team is very aligned to what we’ve laid out on today’s call, and we’re really putting the details in place for execution as opposed to just strategic thinking. So we’re in a good place as a company and a team with respect to the direction we’re highlighting now

Unidentified Analyst: Yeah. Thank you. That’s all really helpful to hear and refreshing. And then one other kind of like logistic question for you, John, what is included in the guidance in terms of contribution from WildHealth to the extent you can share? Thanks.

John Collins: Sure. Very little in the guide from WildHealth. There is a mid-single-digit expectation, low-to-mid-single-digit expectation per full year that would be baked in to the overall full-year 2024 guide. And again, we had last year, just to ensure it’s clear, we had an over — a more than $8 million contribution from Medicare reimbursement that occurred in the second half of 2023 that certainly will not reoccur in 2024.

Operator: Thank you, sir. Ladies and gentlemen, we have reached the end of our call today. Thank you for joining us and you may now disconnect your lines.